All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ALIGOS THERAPEUTICS, INC. Last Reported: 5/31/2024 Stock Symbol: ALGS

Business Address

ONE CORPORATE DR., 2ND FLOOR

SOUTH SAN FRANCISCO , CA US 94080

Mailing Address

ONE CORPORATE DR., 2ND FLOOR

SOUTH SAN FRANCISCO , CA US 94080
Phone Number: (800) 466-6059 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 9/30/2023 6/30/2023 9/30/2022 6/30/2022 9/30/2021 6/30/2021 12/31/2020 10/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 12/31/2018 7/31/2018 1/31/2018
Cash and Cash Equivalents $24,151,000.00 $70,429,000.00 $90,828,000.00 $86,440,000.00 $71,172,000.00 $239,734,000.00 $187,650,000.00 $220,383,000.00 -- $31,816,000.00 -- $25,415,000.00 $69,565,000.00 $21,130,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $118,064,000.00 $74,643,000.00 $94,243,000.00 $150,093,000.00 $167,685,000.00 $248,670,000.00 $196,642,000.00 $250,017,000.00 -- $73,693,000.00 -- -- $120,226,000.00 -- -- -- -- --
Property Plant and Equipement $3,046,000.00 $3,646,000.00 $3,951,000.00 $5,250,000.00 $5,781,000.00 $6,272,000.00 $6,955,000.00 $8,007,000.00 -- $8,592,000.00 -- -- $8,517,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $625,000.00 $623,000.00 $624,000.00 $653,000.00 $616,000.00 $748,000.00 $1,481,000.00 $377,000.00 -- $2,844,000.00 -- -- $188,000.00 -- -- -- -- --
Total Assets $127,902,000.00 $85,852,000.00 $106,130,000.00 $164,069,000.00 $182,523,000.00 $263,068,000.00 $211,876,000.00 $265,302,000.00 -- $92,183,000.00 -- -- $146,520,000.00 -- -- -- -- --
Accounts Payable $2,842,000.00 $2,941,000.00 $3,241,000.00 $2,931,000.00 $2,762,000.00 $2,601,000.00 $1,593,000.00 $3,313,000.00 -- $7,682,000.00 -- -- $3,767,000.00 -- -- -- -- --
Accrued Liabilities $12,043,000.00 $12,322,000.00 $13,795,000.00 $13,678,000.00 $12,824,000.00 $22,760,000.00 $19,060,000.00 $16,564,000.00 -- $9,782,000.00 -- -- $7,599,000.00 -- -- -- -- --
Total Current Liabilities $68,106,000.00 $31,031,000.00 $36,495,000.00 $42,056,000.00 $45,542,000.00 $46,057,000.00 $42,992,000.00 $45,263,000.00 -- $46,285,000.00 -- -- $29,332,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $580,973,000.00 $513,225,000.00 $509,998,000.00 $499,082,000.00 $495,538,000.00 $482,615,000.00 $401,363,000.00 $394,963,000.00 -- $3,620,000.00 -- -- $1,421,000.00 -- -- -- -- --
Accumulated Other Comprehensive Loss $476,000.00 $497,000.00 $497,000.00 $159,000.00 $50,000.00 $-250,000.00 $-251,000.00 $-188,000.00 -- $32,000.00 -- -- $-115,000.00 -- -- -- -- --
Accumulated Deficit $-521,700,000.00 $-458,905,000.00 $-440,900,000.00 $-377,200,000.00 $-358,611,000.00 $-265,358,000.00 $-232,232,000.00 $-174,740,000.00 -- $-140,320,000.00 -- -- $-66,197,000.00 -- -- -- -- --
Total Stockholders' Equity $59,796,000.00 $54,821,000.00 $69,635,000.00 $122,013,000.00 $136,981,000.00 $217,011,000.00 $168,884,000.00 $220,039,000.00 -- $-136,668,000.00 $-104,573,000.00 $-83,941,000.00 $-64,891,000.00 $-47,016,000.00 $-33,372,000.00 $-13,749,000.00 -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $127,902,000.00 $85,852,000.00 $106,130,000.00 $164,069,000.00 $182,523,000.00 $263,068,000.00 $211,876,000.00 $265,302,000.00 -- $92,183,000.00 -- -- $146,520,000.00 -- -- -- -- --

Statement of Operations

Date 3/31/2024 9/30/2023 6/30/2023 9/30/2022 6/30/2022 9/30/2021 6/30/2021 12/31/2020 10/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 12/31/2018 7/31/2018 1/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $16,366,000.00 $50,783,000.00 $16,781,000.00 $17,791,000.00 $48,186,000.00 $28,132,000.00 $47,422,000.00 $79,890,000.00 -- $51,809,000.00 -- $17,302,000.00 $44,038,000.00 $29,065,000.00 -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $23,032,000.00 $22,310,000.00 $26,027,000.00 $23,054,000.00 $24,086,000.00 $34,605,000.00 $59,759,000.00 $97,834,000.00 -- $63,548,000.00 -- $20,721,000.00 $54,043,000.00 $35,607,000.00 -- -- -- --
Loss from Operations $-22,046,000.00 $-62,130,000.00 $-43,059,000.00 $-74,898,000.00 $-20,393,000.00 $-33,068,000.00 $-57,304,000.00 $-97,834,000.00 -- $-63,548,000.00 -- $-20,721,000.00 $-54,043,000.00 $-35,607,000.00 -- -- -- --
Loss Before Income Taxes $-34,839,000.00 $-58,962,000.00 $-40,950,000.00 $-18,664,000.00 $-55,440,000.00 -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.22 $-1.38 $-0.43 $-1.74 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 156,154,156 43,209,656 43,063,615 42,761,928 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.22 $-0.41 $-0.43 $-0.44 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 156,154,156 43,496,975 43,063,615 42,647,732 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 320,000,000 320,000,000 320,000,000 320,000,000 320,000,000 320,000,000 320,000,000 320,000,000 320,000,000 278,000,000 -- -- 278,000,000 -- -- -- 149,000,000 20,000,000
Common Stock Shares Outstanding 75,668,521 43,502,582 43,502,582 42,815,593 42,808,288 42,611,847 38,200,121 36,606,247 -- 4,104,585 -- -- 3,927,803 -- -- -- -- --
Common Stock Value $7,000.00 $4,000.00 -- $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 -- -- -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- $0.00 -- -- -- -- $0.00
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- $0.00 -- -- -- $0.00 --
Share Price -- -- -- -- -- -- -- -- -- $650.00 -- -- $753.00 -- -- -- -- --
Copyright 2024 PursePoor.com